Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real-life Treatment Outcomes of Ravulizumab in PNH
Sponsor: AstraZeneca
Summary
The PNH-RECORD study, a Polish multicenter observational (non-interventional), open-label, retrospective with prospective follow-up.
Official title: Real-life Treatment Outcomes of Ravulizumab in Polish Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH). Prospective and Retrospective, Multicenter, Non-interventional Study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
64
Start Date
2025-02-06
Completion Date
2028-08-01
Last Updated
2026-04-01
Healthy Volunteers
No
Conditions
Interventions
Ravulizumab
open-label arm with ravulizumab administrated within the scope of routine clinical practice
Locations (11)
Research Site
Bialystok, Poland
Research Site
Brzozów, Poland
Research Site
Bydgoszcz, Poland
Research Site
Gdansk, Poland
Research Site
Krakow, Poland
Research Site
Lodz, Poland
Research Site
Lublin, Poland
Research Site
Opole, Poland
Research Site
Szczecin, Poland
Research Site
Warsaw, Poland
Research Site
Wałbrzych, Poland